Post

Strategies and innovations for reducing drug product loss in sterile filling  

Sterile filling is a critical step in pharmaceutical primary packaging; the transfer of sterile drug product into its final primary …

Seagen reports positive data on Tukysa from Phase III breast cancer trial

Seagen has reported positive topline data from the Phase III HER2CLIMB-02 clinical trial investigating Tukysa (tucatinib) in combination with the …

Geron completes 50% subject enrolment in Phase III myelofibrosis trial

Geron has completed 50% subject enrolment in the Phase III IMpactMF clinical trial of its telomerase inhibitor, imetelstat, to treat …

Syros reports initial findings from acute myeloid leukaemia trial

Syros Pharmaceuticals has reported encouraging initial findings from its SELECT-AML-1 Phase II clinical trial of tamibarotene plus venetoclax and azacitidine …

Q&A: Dr Christina Yap talks about SPIRIT and CONSORT guidance

The CONSORT2010 guidance is used globally when academics are writing papers on clinical trials, providing a checklist for researchers to …